Table 1 Clinical and Metabolic Characteristics of Study Population
| Â | Controls | T1DM | p |
|---|---|---|---|
N | 26 | 16 | Â |
Sex (males, %) | 58 | 68 | = 0.47 |
Age (years) | 19 ± 2 | 18 ± 2 | = 0.12 |
Body mass index (kg/m2) | 21.6 ± 4.2 | 21.7 ± 6.2 | = 0.82 |
Systolic BP (mmHg) | 112 ± 10 | 118 ± 16 | = 0.13 |
Diastolic BP (mmHg) | 67 ± 5 | 66 ± 7 | = 0.94 |
Mean BP (mmHg) | 82 ± 5 | 83 ± 8 | = 0.47 |
Heart rate (bpm) | 70 ± 12 | 69 ± 11 | = 0.88 |
Total cholesterol (mg/dL) | 165 ± 22 | 170 ± 33 | = 0.37 |
HDL-cholesterol (mg/dL) | 58 ± 13 | 54 ± 8 | = 0.36 |
LDL-cholesterol (mg/dL) | 87 ± 19 | 100 ± 21 | = 0.08 |
∫Triglycerides (mg/dL) | 71 [31] | 75 [25] | = 0.94 |
∫Adiponectin (mg/L) | 18.5 [5.5] | 19.0 [4.5] | = 0.09 |
Fasting plasma glucose (mg/dL) | 87 ± 7 | 178 ± 45 | < 0.0001 |
sRAGEs (pg/ml) | 383 ± 152 | 464 ± 187 | = 0.76 |
AGE-dependent AF (arbitrary units) | 1.6 ± 0.3 | 1.7 ± 0.3 | = 0.52 |
∫ EPCs (CD34+/KDR+/10 6 events*) | 74 [150] | 39 [63] | = 0.02 |